{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:59:17Z","timestamp":1760061557575},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/maj.0b013e3181abf66b","type":"journal-article","created":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T03:22:14Z","timestamp":1252466534000},"page":"178-184","source":"Crossref","is-referenced-by-count":2,"title":["Does Poly-N-Acetyl Glucosamine Patch Use Reduce Arteriovenous Fistula and Graft Failure Rates in Hemodialysis Patients With End-Stage Renal Disease?"],"prefix":"10.1016","volume":"338","author":[{"given":"Aynur","family":"\u00dcnalp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Van Natta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis L.","family":"Meinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Ploth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Counts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela H.","family":"Shepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0010","series-title":"U.S. Renal Data System: USRDS 2006 Annual data report: atlas of end-stage renal disease in the United States.","year":"2006"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00000658-198508000-00015","article-title":"Vascular access for hemodialysis: patency rates and results of revision","volume":"202","author":"Palder","year":"1985","journal-title":"Ann Surg"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00000658-198711000-00019","article-title":"PTFE grafts for hemodialysis access: techniques for insertion and management of complications","volume":"206","author":"Raju","year":"1987","journal-title":"Ann Surg"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jama.1983.03330260037028","article-title":"Polytetrafluoroethylene graft survival in hemodialysis","volume":"249","author":"Munda","year":"1983","journal-title":"JAMA"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0002-9610(94)90237-2","article-title":"Thrombolysis versus thrombectomy for occluded hemodialysis grafts","volume":"167","author":"Schuman","year":"1994","journal-title":"Am J Surg"},{"issue":"suppl 3","key":"10.1097\/MAJ.0b013e3181abf66b_bb0035","first-page":"S154","article-title":"National Kidney Foundation: DOQI clinical practice guidelines for vascular access","volume":"30","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0040","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1046\/j.1523-1755.1999.00409.x","article-title":"Vascular access for hemodialysis","volume":"55","author":"Schwab","year":"1999","journal-title":"Kidney Int"},{"issue":"suppl 1","key":"10.1097\/MAJ.0b013e3181abf66b_bb0045","first-page":"S137","article-title":"National Kidney Foundation: K\/DOQI clinical practice guidelines for vascular access: update 2000","volume":"37","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mva.2001.117890","article-title":"Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study","volume":"34","author":"Gibson","year":"2001","journal-title":"J Vasc Surg"},{"issue":"suppl 1","key":"10.1097\/MAJ.0b013e3181abf66b_bb0055","first-page":"S176","article-title":"National Kidney Foundation: NKF-K\/DOQI clinical practice guidelines for vascular access: update 2006","volume":"48","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0060","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1681\/ASN.2005050615","article-title":"Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint","volume":"17","author":"Roy-Chaudhury","year":"2006","journal-title":"J Am Soc Nephol"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0065","first-page":"17","article-title":"Maintenance of permanent hemodialysis vascular access patency","volume":"22","author":"Berkoben","year":"1995","journal-title":"ANNA J"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0070","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/01.TA.0000136741.66698.9D","article-title":"Isolation, purification, and characterization of poly-N-acetyl glucosamine use as a hemostatic agent","volume":"57","author":"Vournakis","year":"2004","journal-title":"J Trauma"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0075","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0039-6060(99)70092-9","article-title":"A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent","volume":"126","author":"Cole","year":"1999","journal-title":"Surgery"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-4804(03)00161-6","article-title":"The RDH bandage: hemostasis and survival in a lethal aortotomy hemorrhage model","volume":"113","author":"Vournakis","year":"2003","journal-title":"J Surg Res"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0085","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/01.TA.0000136749.20063.F0","article-title":"Evaluation of poly-N-acetyl glucosamine as a hemostatic agent in patients undergoing cardiac catheterization: a double-blind, randomized study","volume":"57","author":"Najjar","year":"2004","journal-title":"J Trauma"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.TA.0000079375.69610.89","article-title":"Modified rapid deployment hemostat bandage reduces blood loss and mortality in coagulopathic pigs with severe liver injury","volume":"55","author":"Jewelewicz","year":"2004","journal-title":"J Trauma"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.TA.0000147501.64610.AFS","article-title":"Modified rapid deployment hemostat bandage terminates bleeding in coagulopathic patients with severe visceral injuries","volume":"57","author":"King","year":"2004","journal-title":"J Trauma"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0100","first-page":"305","article-title":"Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures","volume":"14","author":"Nader","year":"2002","journal-title":"J Invasive Cardiol"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jbm.a.30877","article-title":"Hemostatic properties of glucosamine-based materials","volume":"80A","author":"Fischer","year":"2007","journal-title":"J Biomed Mater Res"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/jsre.2001.6323","article-title":"Vascular effects of poly-N-acetylglucosamine in isolated rat aortic rings","volume":"102","author":"Ikeda","year":"2002","journal-title":"J Surg Res"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0115","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1016\/j.biomaterials.2005.01.023","article-title":"Synergistic platelet integrin signaling and factor XII activation in poly-N-acetyl glucosamine fiber mediated hemostasis","volume":"26","author":"Fischer","year":"2005","journal-title":"Biomaterials"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0120","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1088\/1748-6041\/3\/1\/015009","article-title":"Non-classical processes in surface hemostasis: mechanisms for the poly-N-acetyl glucosamine-induced alteration of red blood cell morphology and prothrombogenicity","volume":"3","author":"Fischer","year":"2008","journal-title":"Biomed Mater"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0125","first-page":"212A","article-title":"Control of post dialysis bleeding in patients on chronic oral anticoagulation therapy","volume":"10","author":"Meyer","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000112544","article-title":"Poly-N-acetyl glucosamine nanofibers regulate endothelial cell movement and angiogenesis: dependency on integrin activation of Ets1","volume":"45","author":"Vournakis","year":"2008","journal-title":"J Vasc Res"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0135","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/01.ta.0000244382.13937.a8","article-title":"Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db\/db mouse","volume":"64","author":"Pietramaggiori","year":"2008","journal-title":"J Trauma"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0140","series-title":"Stata Statistical Software: Release 9.","year":"2007"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0145","series-title":"Generalized linear models,","author":"McCullagh","year":"1989"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.semvascsurg.2003.11.006","article-title":"Medical factors affecting patency of arteriovenous access","volume":"17","author":"Abularrage","year":"2004","journal-title":"Semin Vasc Surg"},{"key":"10.1097\/MAJ.0b013e3181abf66b_bb0160","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/ajkd.2002.36895","article-title":"Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"40","author":"Saran","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291531870X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291531870X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T08:43:56Z","timestamp":1558514636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296291531870X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S000296291531870X"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e3181abf66b","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}